Premier Biomedical's competitors

Premier Biomedical's competitors include Biogen, Otonomy, Chimerix and Synthetic Biologics
Add company...
Premier Biomedical
Premier Biomedical, a research-based firm, develops medical products for Alzheimer's disease, traumatic brain injury, and more.
Biogen
Biogen develops, markets and manufactures therapies for people living with serious neurological, autoimmune and rare diseases.
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Chimerix
Chimerix is a biopharmaceutical company discovering, developing and commercializing medicines that improve outcomes for immunocompromised patients.
Synthetic Biologics
Synthetic Biologics is a late-stage clinical company developing therapeutics designed to preserve the microbiome.
Founding Date
Founding Date
2010
Founding Date
1978
Founding Date
2008
Founding Date
2000
Founding Date
2001
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Jackson Center, US HQ
Locations
Cambridge, US HQ
Locations
San Diego, US HQ
Locations
Durham, US HQ
Locations
Rockville, US HQ
Employees
Employees
N/A
Employees
7,300 1% decrease
Employees
139
Employees
87
Employees
28
Valuation ($)
Valuation ($)
2.9 m
Valuation ($)
62.2 b
Valuation ($)
175.8 m
Valuation ($)
236.3 m
Valuation ($)
53.2 m
Facebook followers
Facebook followers
N/A
Facebook followers
2.7 k
Facebook followers
1.1 k
Facebook followers
N/A
Facebook followers
439
Twitter followers
Twitter followers
171
Twitter followers
18.5 k
Twitter followers
270
Twitter followers
885
Twitter followers
1.2 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$11.4b (FY, 2016)
Revenue (est.)
$683k (FY, 2016)
Revenue (est.)
$5.7m (FY, 2016)
Revenue (est.)
N/A
Net income
Net income
($1.8m) (FY, 2016)
Net income
$3.7b (FY, 2016)
Net income
($110.6m) (FY, 2016)
Net income
($76.4m) (FY, 2016)
Net income
($27.8m) (FY, 2016)

Operating

Phase I Trials
Phase I Trials
N/A
Phase I Trials
4 (FY, 2016)
Phase I Trials
1 (FY, 2016)
Phase I Trials
N/A
Phase I Trials
N/A
Phase II Trials
Phase II Trials
N/A
Phase II Trials
10 (FY, 2016)
Phase II Trials
2 (FY, 2016)
Phase II Trials
N/A
Phase II Trials
N/A
Phase III Trials
Phase III Trials
N/A
Phase III Trials
2 (FY, 2016)
Phase III Trials
2 (FY, 2016)
Phase III Trials
N/A
Phase III Trials
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles